Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2016, Article ID 7174319, 10 pages
http://dx.doi.org/10.1155/2016/7174319
Research Article

Infusion of Bone Marrow Mesenchymal Stem Cells Attenuates Experimental Severe Acute Pancreatitis in Rats

1Department of Gastroenterology, Shanghai First People’s Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200080, China
2Department of Cell Biology, Second Military Medical University, Shanghai 200433, China
3Department of Emergency, Changhai Hospital, Second Military Medical University, Shanghai 200433, China
4Department of Gastroenterology, Changhai Hospital, Second Military Medical University, Shanghai 200433, China
5Department of Gastroenterology, Shanghai Sixth People’s Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 201306, China

Received 22 December 2015; Revised 31 March 2016; Accepted 28 April 2016

Academic Editor: Albert Rizvanov

Copyright © 2016 Hang Zhao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. A. Banks, T. L. Bollen, C. Dervenis et al., “Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensus,” Gut, vol. 62, no. 1, pp. 102–111, 2013. View at Publisher · View at Google Scholar
  2. M. Sharma, D. Banerjee, and P. K. Garg, “Characterization of newer subgroups of fulminant and subfulminant pancreatitis associated with a high early mortality,” The American Journal of Gastroenterology, vol. 102, no. 12, pp. 2688–2695, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. W. Denham, J. Yang, G. Fink et al., “Gene targeting demonstrates additive detrimental effects of interleukin 1 and tumor necrosis factor during pancreatitis,” Gastroenterology, vol. 113, no. 5, pp. 1741–1746, 1997. View at Publisher · View at Google Scholar · View at Scopus
  4. G. Malleo, E. Mazzon, A. K. Siriwardena, and S. Cuzzocrea, “Role of tumor necrosis factor-α in acute pancreatitis: from biological basis to clinical evidence,” Shock, vol. 28, no. 2, pp. 130–140, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Malleo, E. Mazzon, T. Genovese et al., “Effects of thalidomide in a mouse model of cerulein-induced acute pancreatitis,” Shock, vol. 29, no. 1, pp. 89–97, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Abraham, R. Wunderink, H. Silverman et al., “Efficacy and safety of monoclonal antibody to human tumor necrosis factor α in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group,” The Journal of the American Medical Association, vol. 273, no. 12, pp. 934–941, 1995. View at Publisher · View at Google Scholar · View at Scopus
  7. A. S. Paszkowski, B. Rau, J. M. Mayer, P. Möller, and H. G. Beger, “Therapeutic application of caspase 1/interleukin-1β-converting enzyme inhibitor decreases the death rate in severe acute experimental pancreatitis,” Annals of Surgery, vol. 235, no. 1, pp. 68–76, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Ishibashi, H. Zhao, K. Kawabe et al., “Blocking of monocyte chemoattractant protein-1 (MCP-1) activity attenuates the severity of acute pancreatitis in rats,” Journal of Gastroenterology, vol. 43, no. 1, pp. 79–85, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. A. S. Matheus, A. M. Coelho, S. Sampietre et al., “Effect of inhibition of prostaglandin E2 production on pancreatic infection in experimental acute pancreatitis,” HPB, vol. 9, no. 5, pp. 392–397, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. A. S. Gukovskaya, M. Mouria, I. Gukovsky et al., “Ethanol metabolism and transcription factor activation in pancreatic acinar cells in rats,” Gastroenterology, vol. 122, no. 1, pp. 106–118, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Shi, X. Zhao, X. Wang, and R. Andersson, “Role of nuclear factor-κB, reactive oxygen species and cellular signaling in the early phase of acute pancreatitis,” Scandinavian Journal of Gastroenterology, vol. 40, no. 1, pp. 103–108, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Altavilla, C. Famulari, M. Passaniti et al., “Lipid peroxidation inhibition reduces NF-κB activation and attenuates cerulein-induced pancreatitis,” Free Radical Research, vol. 37, no. 4, pp. 425–435, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. I. Virlos, E. Mazzon, I. Serraino et al., “Calpain I inhibitor ameliorates the indices of disease severity in a murine model of cerulein-induced acute pancreatitis,” Intensive Care Medicine, vol. 30, no. 8, pp. 1645–1651, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. A. U. Steinle, H. Weidenbach, M. Wagner, G. Adler, and R. M. Schmid, “NF-κB/Rel activation in cerulein pancreatitis,” Gastroenterology, vol. 116, no. 2, pp. 420–430, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Algül, M. Treiber, M. Lesina et al., “Pancreas-specific RelA/p65 truncation increases susceptibility of acini to inflammation-associated cell death following cerulein pancreatitis,” The Journal of Clinical Investigation, vol. 117, no. 6, pp. 1490–1501, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Bai, Y. Liu, L. Jia et al., “Severe acute pancreatitis in China: etiology and mortality on 1976 patients,” Pancreas, vol. 35, no. 3, pp. 232–237, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Jiang, B. N. Jahagirdar, R. L. Reinhardt et al., “Pluripotency of mesenchymal stem cells derived from adult marrow,” Nature, vol. 418, no. 6893, pp. 41–49, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Takahashi, K. Tanabe, M. Ohnuki et al., “Induction of pluripotent stem cells from adult human fibroblasts by defined factors,” Cell, vol. 131, no. 5, pp. 861–872, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. K. Takahashi and S. Yamanaka, “Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors,” Cell, vol. 126, no. 4, pp. 663–676, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Wernig, A. Meissner, R. Foreman et al., “In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state,” Nature, vol. 448, no. 7151, pp. 318–324, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. V. Sordi, M. L. Malosio, F. Marchesi et al., “Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets,” Blood, vol. 106, no. 2, pp. 419–427, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Bilen, F. Pinarli, F. Ak et al., “Treatment efficacy with bone marrow derived mesenchymal stem cells and minocycline in rats after cerebral ischemic injury,” Stem Cell Reviews and Reports, vol. 9, no. 2, pp. 219–225, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Li and S. Ikehara, “Bone-marrow-derived mesenchymal stem cells for organ repair,” Stem Cells International, vol. 2013, Article ID 132642, 8 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Xin, Y. Li, Z. Liu et al., “MiR-133b promotes neural plasticity and functional recovery after treatment of stroke with multipotent mesenchymal stromal cells in rats via transfer of exosome-enriched extracellular particles,” STEM CELLS, vol. 31, no. 12, pp. 2737–2746, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Corcione, F. Benvenuto, E. Ferretti et al., “Human mesenchymal stem cells modulate B-cell functions,” Blood, vol. 107, no. 1, pp. 367–372, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Aggarwal and M. F. Pittenger, “Human mesenchymal stem cells modulate allogeneic immune cell responses,” Blood, vol. 105, no. 4, pp. 1815–1822, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. K. H. Jung, S. U. Song, T. Yi et al., “Human bone marrow-derived clonal mesenchymal stem cells inhibit inflammation and reduce acute pancreatitis in rats,” Gastroenterology, vol. 140, no. 3, pp. 998–1008, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. H.-F. Cui and Z.-L. Bai, “Protective effects of transplanted and mobilized bone marrow stem cells on mice with severe acute pancreatitis,” World Journal of Gastroenterology, vol. 9, no. 10, pp. 2274–2277, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. J. M. Laukkarinen, G. J. D. Van Acker, E. R. Weiss, M. L. Steer, and G. Perides, “A mouse model of acute biliary pancreatitis induced by retrograde pancreatic duct infusion of Na-taurocholate,” Gut, vol. 56, no. 11, pp. 1590–1598, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Schmidt, D. W. Rattner, K. Lewandrowski et al., “A better model of acute pancreatitis for evaluating therapy,” Annals of Surgery, vol. 215, no. 1, pp. 44–56, 1992. View at Publisher · View at Google Scholar · View at Scopus
  31. G. Chamberlain, J. Fox, B. Ashton, and J. Middleton, “Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing,” Stem Cells, vol. 25, no. 11, pp. 2739–2749, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. Sato, H. Araki, J. Kato et al., “Human mesenchymal stem cells xenografted directly to rat liver are differentiated into human hepatocytes without fusion,” Blood, vol. 106, no. 2, pp. 756–763, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. M. T. Abdel Aziz, H. M. Atta, S. Mahfouz et al., “Therapeutic potential of bone marrow-derived mesenchymal stem cells on experimental liver fibrosis,” Clinical Biochemistry, vol. 40, no. 12, pp. 893–899, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. P. G. Lankisch, T. Blum, P. Maisonneuve, and A. B. Lowenfels, “Severe acute pancreatitis: when to be concerned?” Pancreatology, vol. 3, no. 2, pp. 102–110, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. M. W. Russo, J. T. Wei, M. T. Thiny et al., “Digestive and liver diseases statistics, 2004,” Gastroenterology, vol. 126, no. 5, pp. 1448–1453, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. E. Karaoz, A. Okcu, Z. S. Ünal, C. Subasi, O. Saglam, and G. Duruksu, “Adipose tissue-derived mesenchymal stromal cells efficiently differentiate into insulin-producing cells in pancreatic islet microenvironment both in vitro and in vivo,” Cytotherapy, vol. 15, no. 5, pp. 557–570, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. G. Yin, G. Hu, R. Wan et al., “Role of bone marrow mesenchymal stem cells in L-arg-induced acute pancreatitis: effects and possible mechanisms,” International Journal of Clinical and Experimental Pathology, vol. 8, no. 5, pp. 4457–4468, 2015. View at Google Scholar · View at Scopus
  38. W. Chen, M. Li, H. Cheng et al., “Overexpression of the mesenchymal stem cell Cxcr4 gene in irradiated mice increases the homing capacity of these cells,” Cell Biochemistry and Biophysics, vol. 67, no. 3, pp. 1181–1191, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. S. Law and S. Chaudhuri, “Mesenchymal stem cell and regenerative medicine: regeneration versus immunomodulatory challenges,” American Journal of Stem Cells, vol. 2, no. 1, pp. 22–38, 2013. View at Google Scholar
  40. D.-Q. Tang, L.-Z. Cao, B. R. Burkhardt et al., “In vivo and in vitro characterization of insulin-producing cells obtained from murine bone marrow,” Diabetes, vol. 53, no. 7, pp. 1721–1732, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. S.-H. Oh, T. M. Muzzonigro, S.-H. Bae, J. M. LaPlante, H. M. Hatch, and B. E. Petersen, “Adult bone marrow-derived cells trans-differentiating into insulin-producing cells for the treatment of type I diabetes,” Laboratory Investigation, vol. 84, no. 5, pp. 607–617, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. L. Wang, X.-H. Tu, P. Zhao, J.-X. Song, and Z.-D. Zou, “Protective effect of transplanted bone marrow-derived mesenchymal stem cells on pancreatitis-associated lung injury in rats,” Molecular Medicine Reports, vol. 6, no. 2, pp. 287–292, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. N. Liu, A. Patzak, and J. Zhang, “CXCR4-overexpressing bone marrow-derived mesenchymal stem cells improve repair of acute kidney injury,” American Journal of Physiology—Renal Physiology, vol. 305, no. 7, pp. F1064–F1073, 2013. View at Publisher · View at Google Scholar · View at Scopus
  44. J. S. Van Arnam, E. Herzog, J. Grove et al., “Engraftment of bone marrow-derived epithelial cells,” Stem Cell Reviews, vol. 1, no. 1, pp. 21–27, 2005. View at Publisher · View at Google Scholar · View at Scopus